I. INTRODUCTION
LZHEIMER is known as the most common form of dementia between people over 65 years old. There are more than 5 million people in the United States out of 26 million in the world afflicted by the Alzheimer's disease and its financial and psychological expenditures are on the rise continuously [1] . It is anticipated that the number of these people will be twice as now during next 20 years. Native Alzheimer's disease whittles some of capabilities starting with memorial and spreading to lingual, cognitive, behavioral and functional ones but that the onset of disease starts almost decades before appearing these symptoms [2] . MCI is a transitional state in moving from NC to AD [3] . A person, who has MCI complains about some memory impairments but still can do his/her personal activities and cannot be classified as Alzheimer holder. It has been implied that MCI has 4-6-fold increased risk of converting to Alzheimer's disease beside normal populations and around 50% of them convert to Alzheimer's disease during a period of three years [1] .
The need to diagnose Alzheimer's disease in the early stages seems to be crucial. It comes from the fact that pharmacotherapy treatments for preventing disease progression or at least decelerating it must be started as early as possible before widespread infestation of the brain. In addition, developments of new pharmacotherapy treatments need to monitor the influence of drugs in different parts of brain [4] .
Diagnostics based on clinical symptoms is prone to error and their test-retest accuracy is very low [5] . The cause of this unreliability could be different educational level of subjects and their cognitive capabilities so that some people can cope with prodromal cognitive impairments. This makes the diagnostic results more confusing. On the other hand, the clinical symptoms of disease are mostly hidden by the late age of disease and appear only when the brain structures have been infested by the disease. It has been proved that histological and pathological onset of disease starts 10-15 years before manifestation of clinical signals and these pathological symptoms seem to be useful for disease evaluation.
Neuroimaging methods are used for evaluating anatomical degenerations caused by disease. Different imaging modalities such as Positron Emission Tomography (PET) [6] [7] [8] , Functional Magnetic Resonance Imaging (fMRI) [9] [10] [11] [12] and also structural Magnetic Resonance Imaging (MRI) have been used in lots of previous works. Because of high availability, noninvasive nature and high quality, MR Images are suitable for identifying subtle differences in brain anatomies that occur due to the disease development and progression [13] .
Finding a few quantitative measures to diagnose Alzheimer's disease and evaluate its progression is considered as objective in some of MRI processing methods. To this end, MR Images of some anatomical brain structures have been studied. In terms of the mass of invasion and its continuance, each of diverse tissues shows different discriminative power and accuracy. In the following, the major anatomical parts in each of three main brain tissues -Cerebrospinal Fluid (CSF), Gray Matter (GM) and White Matter (WM) -are described and their discriminative power in classifying subjects into different pairs of populations (AD vs. MCI, AD vs. NC, NC vs. MCI, MCI-MCI vs. MCI-AD) are evaluated. In other words, subjects supposed to be categorized into five different populations. Those who have their normal control (NC), suffer from mild cognitive impairments (MCI), felt in Alzheimer's disease, MCI subject who remain in MCI (MCI-MCI) or MCI subjects who convert to AD (MCI-AD).
Clinical tests are the most common form of tests used for diagnosing Alzheimer's disease. The most commonly used test is MMSE. This examination is used to evaluate the capabilities of the subject under the test including orientation, memory, arithmetic, recall, naming and etc. Total maximum score of the test is 30 and it is assumed that everybody must normally score 26 or above [14] [15] . Clinical Dementia Rating (CDR) is another test of this category. It characterizes six major abilities including memory, orientation, judgment & problem solving, community affairs, home & hobbies, and personal care. Its total maximum score is 3 and the minimum normal score for this test is assumed to be 2 [16] .
In section 2, some of the most important parts of the brain are explained which are likely to be influenced by AD. They are categorized into their three major belonging tissues (CSF, GM and WM) and the influence of disease on them is investigated. Section 2.1 explores CSF structures, section 2.2 is about GM structures and 2.3 is focused on WM. Afterwards in section 3, evaluating methods are mentioned and discussed whether they are used for evaluating intergroup differences (e.g. difference between AD and MCI groups) or for classification of subjects (e.g. subjects which are classified as NC's or AD holders) which is an important factor in making it a clinically practical system and eliminating or reducing any human manual intervention. In section 4 the results of diagnostics which is done by various methods are compared and based on these comparisons, section 5 concludes which parts of brain are most important in diagnosing AD and in various grades of disease.
II. MAJOR TISSUES IN BRAIN MRI
Cerebrospinal fluid, gray matter and white matter are the major tissues which can be used to categorize brain parts into. This paper focuses on these tissues and investigates the impact of AD in each of them.
A. Cerebrospinal Fluid (Csf)
Cerebrospinal fluid or brain juice is the liquid part of the brain, which surrounds it and is located between brain and skull. This liquid is included in ventricle and Sulcus. Researches show that these two parts are influenced by AD. Effects of AD on these parts are mostly in the form of enlarging CSF area [17] .
B. Ventricle
Empty spaces within the cerebral hemispheres and brain steam is called ventricle. These empty spaces are filled with CSF liquid and its volume change is an indicator for Alzheimer's disease. It has been revealed that ventricle enlarges gradually in AD patients [18] ; [5] and can be used as a marker of AD.
Sulcus Area
Sulcus or sulci are grooves or fissures of the brain, which are filled with CSF liquid like the ventricle. The volume of the liquid occupying the sulcus can be used as indicator of AD. There is no specific pattern of Sulcus network for all people and everybody has its own peculiar sulcus structure. But some of them are common to all people. Lateral sulcus is one of these common features in all people and volume of CSF inside it has been used as a biomarker in diagnosing AD patients [18] . Furthermore, circular sulcus of the insula and the volume of CSF inside it has pointed out good characteristics in evaluating AD [5] .
C. Gray Matter (Gm)
Gray matter is one of two major tissues of the brain body (White Matter & Gray Matter). It consists of cell bodies of neural system in contrast to myelinated nerve fibers, which constitute the White Matter of the brain. Gray matter is degenerated by the AD in various parts of it and Neuroimaging research is focused mostly on this tissue.
Cortex Lobes
Four major lobes of cortex -frontal lobe, parietal lobe, temporal lobe, and occipital lobe-are gray matter structures which are interested in diagnosing AD. Volume of temporal lobe has been used as one of the most common discriminative measures for diagnosing AD. Results have revealed a prominent volume loss in MCI and AD holders regarding NC subjects [1, [4] [5] [18] [19] [20] [21] [22] [23] . This effect has been more eminent in the left side compared to the right side of temporal lobe [1] . In contrast with temporal lobe, volume loss in frontal and parietal lobes are subtle for both MCI and AD subjects with respect to NC [1] . The rate of atrophy in frontal and parietal lobes are almost the same [1] but in temporal lobe there are a noticeable volume loss for MCI and AD holders. It is implied that temporal lobe is more discriminative than the former ones in diagnosing AD and its power is more rousing in the left temporal lobe than the right one. Generally, occipital lobe does not show any considerable volume loss and there is some slight volume increase for MCI and especially for AD subjects [1] . But some of researches show that the regional volumetric measures of occipital lobe can be used in classifying subjects [4] . These ambiguities may arise because of the bias in datasets, preprocessing methods or the way of evaluating results.
Hippocampus
Hippocampus as a principTEXl part of temporal lobe has been mostly used for diagnosing AD [1, 5, 13, 20, [24] [25] [26] [27] [28] [29] .
Although the results show volume loss of hippocampus in MCI and especially AD subjects, but its volume loss is petty compared to that of temporal lobe as its inclusive global anatomical structure [1] . Left hippocampus show more discriminating power than the right one, as it was for the left side of temporal lobe too [1, 30] .
Entorhinal Cortex
This brain structure is located close to hippocampus and is the main preprocessor and feeder of signals to it. With respect to its spatial location and adjacency to hippocampus, it seems to be one of the affected parts of the brain in AD. Investigations confirm this hypothesis and assert the differentiating power of it in evaluating group differences and diagnosing disease [4, 28, [31] [32] [33] . Some findings also show that Entorhinal cortex is the first anatomical structure which is influenced in MCI subjects even before hippocampus [34] .
Cortical Tickness And Volume
Regional cortical thickness and its shape parameters can be used for differentiating AD, MCI and NC subjects [4, [35] [36] [37] [38] [39] . Cortical thickness and volume of cortex have a high discriminative power so that these can be used to avoid some sort of manual errors [4, [40] [41] [42] . It is implied that the volume of cortex is more definitive feature than its thickness and diagnostics using its volume are more accurate than those which are based on its thickness [40] .
Other Region Of Interest (Roi) In Gray Matter
Whole brain has been investigated for finding influenced parts of the brain which can be used to evaluate disease progression [19, [43] [44] . These discriminative parts of the brain do not necessarily follow the anatomical boundaries of brain structures and have to be specified by their specific boundaries.
To classify subjects, some parts of the brain such as anterior cingulate gyrus extending towards the orbit frontal cortex as well as the sub cortical thalamic-basal ganglia brain areas have been used as well [19, 22] .
Volume loss in some of gyries like insula-lingual gyri, parahippocampal gyrus, inferior, middle and superior temporal gyri, fusiform gyri, precentral gyri, inferior, middle and superior frontal gyri, lingual gyri [4, [31] [32] 45] have been used to evaluate disease progression. Accordingly, atrophy rate in structures such as amygdala, putamen, temporal pole, frontal pole and some parts of cortex like anterior and posterior cingulate cortices, precuneus cortex, orbitofrontal cortices, isthmus of cingulated cortex [4, 20, 22, [31] [32] , frontal operculum, transverse temporal cortex, banks of superior temporal sulcus and bilateral accumbens [4] , insula [20] [21] , connections between right frontal regions (inferior frontal, middle frontal and superior frontal gyri) to the substantia nigra, right superior frontal gyrus to left medial orbital gyrus connections and also connections between the caudate and substantia nigra and between the right inferior frontal gyrus and right post central gyrus [45] indicate the differences between populations.
D. White Matter (Wm)
In addition to GM anatomies, WM volume is also tested for diagnosing Alzheimer's disease [1, 5, [46] [47] [48] . Temporal lobe WM atrophy can be used as a measure in evaluating AD progression [20] . Accordingly, parahippocampal WM and WM areas in regions with direct and secondary connections to the medial temporal lobe has signified a good definitive power in diagnosing AD [49] . It is revealed that white matter volume reductions also can be found predominant in some other areas like superior and inferior frontal gyrus, precentral gyrus, sub-gyrus in parietal lobe, temporal lobe, corpus callosum, inferior longitudinal fasciculus and cingulate fasciculus [50] [51] .
III. EVALUATION METHODS
Evaluation method of results can be categorized into two major types. Some of the methods use their findings to correlate them with clinical measures such as Mini-Mental State Examination (MMSE) and Clinical Dementia Rating (CDR) [1, 13, 20, 22, 52] . In fact, they are trying to diagnose the disease and find the correlation between their findings and clinically registered scores. Besides them, some other methods just use the results to differentiate between population groups and will not consider the clinical results. These methods try to find the differences between groups without diagnosing them [53] [54] [55] .
In addition to the above methods for differentiating between group populations or classification of subjects into groups, some new methods have focused on continuous regression instead of discrete classification of subjects. Indeed, they are trying to find a relationship between anatomical degeneration of brain structures in MR images and clinical measures such as MMSE or CDR. These methods finally map each subject's MR image to a quantitative clinical score [56] .
Some of methods use a pre-specified region of interest (ROI), which has mostly delineated manually by an expert. These methods are time consuming and prone to error. In addition, they do not use all the information which are embedded in a 3D MR image and are limited in using spatial information [21] . To overcome these problems and making it practical in clinical trials and easier to implement, some methods have been developed, which process the whole brain without regarding any ROI and try to find the most discriminative areas (Voxels) of the brain which can be used in diagnosing AD and evaluating its progression [21, 54, [57] [58] [59] [60] .
Therewith, for the sake of making them as practical as possible with enough accuracy, some researches have been done to automate (or at least semi-automate) the diagnostic process [13, 38] .
IV. CURRENT DIAGNOSTIC RESULTS
Diagnostic accuracy of anatomic structures and their power in evaluating disease progression are not exactly comparable. This is due to the nature of disease and also different preprocessing, registration, feature selection, classification, population in use and etc. Anyway, reported accuracy for diagnosing disease and classifying subjects are as listed in Table I .
Anatomical structures and classification rate based on appropriate information have been exposed for classifying subjects into different categories in Table I . Categories consisted of NC, subjects who felt in AD or who with MCI, MCI patients who converted to AD (MCI-AD) and who remain stable in MCI state (MCI-MCI).
We can infer that the highest accuracy in between is for the most challenging categories, MCI-MCI vs. MCI-AD by using whole brain processing approach. This implies that AD does not follow the anatomical boundaries of brain structures and its impact is pervasive in whole brain.
V. CONCLUSION
Research in diagnosing Alzheimer's disease and evaluating its progression in three major populations of subjects has signified that disease has widespread affects on GM, WM and CSF of the brain [63] . Entorhinal cortex, temporal lobe and hippocampus are the first structures that have been affected by disease in early stages of it [34] . So it seems that their power in differentiating between MCI subjects who convert to AD and non-convertors are higher than other structures. This can be deduced from evidence of MR image processing results [52, 64] . Besides, it has indicated that ventricle enlargement is another indicator for subjects with MCI which eventually converted to AD [65] . In spite of that hippocampal volumetric measures have been widely used for diagnosing AD, it is not a good measure in detecting converter and non-converter MCI subjects. Moreover, shape information of hippocampal has more ability in such subtle classification problems [58, [61] [62] [66] [67] [68] [69] . Another investigation for finding shape differences in other anatomical structures has revealed some differences in amygdale, thalamus, caudate and without any remarkable differences in putamen, globus pallidus [60, 70] .
Some of other parts of the brain such as middle and inferior temporal gyri, bilateral orbitofrontal GM, left fusiform gyrus, right collateral sulcus, and cingulate [54] have been used for diagnosing and evaluation of MCI subjects but with lower accuracy and mostly in combinational form with main structures like hippocampus and temporal lobe. It is pointed out that brain atrophy for MCI subjects primarily is restricted to temporal lobe [58] and degenerations of other structures appear by progress of disease in the future.
According to the abovementioned review, concentrating on anatomical boundaries of brain structures make us to lose some of the information embedded in MR images. In order to reach a high accuracy and classification rate, considering whole the brain as the influenced part by the disease is a preference. So it is necessary to process all of brain voxels or whole brain to find most influenced ones that have highest discriminative power in diagnosing Alzheimer's disease. 
